Does ADAGRASIB Cause Product use issue? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product use issue have been filed in association with ADAGRASIB (KRAZATI). This represents 1.2% of all adverse event reports for ADAGRASIB.
11
Reports of Product use issue with ADAGRASIB
1.2%
of all ADAGRASIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product use issue From ADAGRASIB?
Of the 11 reports, 1 (9.1%) resulted in death, 1 (9.1%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADAGRASIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ADAGRASIB Cause?
Death (272)
Diarrhoea (113)
Hospitalisation (108)
Nausea (87)
Vomiting (79)
Off label use (70)
Asthenia (61)
Fatigue (51)
Decreased appetite (43)
Dehydration (35)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which ADAGRASIB Alternatives Have Lower Product use issue Risk?
ADAGRASIB vs ADALIMUMAB
ADAGRASIB vs ADALIMUMAB-AACF
ADAGRASIB vs ADALIMUMAB-AATY
ADAGRASIB vs ADALIMUMAB-ADAZ
ADAGRASIB vs ADALIMUMAB-ADBM